Skip to search formSkip to main contentSkip to account menu

10 ML Pamidronate Disodium 3 MG/ML Injection

Known as: PAMIDRONATE DISODIUM 3 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Pamidronate Disodium], PAMIDRONATE DISODIUM 3MG/ML SOLN INJ, PAMIDRONATE DISODIUM 3MG/ML INJ,SOLN 
National Institutes of Health

Related topics

Related topics

16 relations
DiphosphonatesDrug AllergyHypercalcemiaInjection

Broader (2)

HORMONES/SYNTHETICS/MODIFIERS,OTHERpamidronate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Copyright by the American Dental Hygienists ' Association Bisphosphonates and Osteonecrosis of the Jaw ( ONJ )
Background. Recent reports have identified an association between osteonecrosis of the jaw or facial bones and treatment with… 
2006
2006
Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate
BackgroundThere is an emerging interest in utilizing local and systemic administration of bisphosphonates in orthopedics. The… 
2005
2005
Uso do Pamidronato na Síndrome SAPHO Pamidronate Treatment in SAPHO Syndrome
ABSTRACT Although relatively rare and still not frequently diagnosed, SAPHO syndrome has specific features that originated the… 
2005
2005
乳癌骨転移に対する pamidronate (アレディア^( !R)) 早期投与の有効性について
2005
2005
A Markov model to evaluate the cost effectiveness of intravenous (IV) zoledronic acid vs IV generic pamidronate or oral ibandronate in the prevention of bone complications in breast cancer patients…
664 Background: Bisphosphonates are commonly used to reduce the burden of skeletal related events [SREs] and bone pain in breast… 
2004
2004
[Treatment of multiple myeloma with intravenous pamidronate. Pain prevention and suppression of hypercalcemia risk].
In a prospective clinical study, with the patient as its own control, we selected patients with stage III multiple myeloma. We… 
Review
2004
Review
2004
The effects of 8-year pamidronate treatment on skeletal morbidity in patients with advanced multiple myeloma
Background . In patients with multiple myeloma (MM) osteolytic bone destruction progresses despite a reduction of tumor mass… 
Review
2001
Review
2001
Advances in the biology and treatment of myeloma bone disease.
Potential antitumor effects of bisphosphonates are discussed, and trial results of zoledronic acid, a bisphosphonate that… 
1997
1997
The determination of pamidronate in pharmaceutical preparations by ion-pair liquid chromatography after derivatization with phenylisothiocyanate.
1984
1984
Structure of Disodium 1,4-Piperazinedicarbodithioate Hexahydrate, 2Na+.C6HsN2S2-.6H20
M r=390.5, monoclinic, P21/c, a= 6.009(2), b=12.185(2), c=11.494(4)A, fl= 92.47 (2) °, V= 840.8 (4) A 3, z = 2, D m = 1.52 (2), D… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)